FDA 483 - William C. Nabours, M.D. - January 16, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of William C. Nabours, M.D. in Lake Charles, LA, a clinical investigator, revealed significant deficiencies in conducting clinical trials. Observations included the enrollment of ineligible subjects who were immediate family members of study staff, violating protocol exclusion criteria. Additionally, the firm failed to maintain adequate and accurate case histories, specifically regarding the reporting of adverse events and concomitant medications in case report forms.
ID · b6ff2b56-8741-400a-8569-d14dff3f0438